About Validus Pharmaceuticals, Inc.

Validus Pharmaceuticals is a portfolio investment of Konanda Pharma Fund I. L.P. which is managed by Konanda Pharma Partners, a private equity fund focused on acquiring branded specialty pharma products.

 Validus is focused on acquiring, reformulating and marketing prescription products relevant to the psychiatry and neurology markets.  Validus seeks to acquire mature products that have well defined and accepted clinical utility relevant to today’s practice of medicine.

Validus’ portfolio currently includes Marplan®, which is indicated for the treatment of depression.  Marplan is a member of the monoamine oxidase inhibitor class of antidepressants.

 

Please click below for more information about Marplan® or Equetro™

CONTACT US 

 

 

Customer Care Center

866-9VALIDUS  

info@validuspharma.com

 

Headquarters

Validus Pharmaceuticals, Inc.

2001 Route 46 East, Suite 310

Parsippany, NJ 07054

 

James R. Hunter

President & CEO

Phone: 973-402-4938

Fax:     973-402-4939

jhunter@validuspharma.com

 

Joseph Lazarich

Chief Marketing Officer

Phone: 973-402-4937

Fax:     973-402-4939

jlazarich@validuspharma.com

Designed by NewAgeSystems